This trial is active, not recruiting.

Condition asthma
Treatment text messages
Sponsor Children's Hospitals and Clinics of Minnesota
Collaborator Health Partners of Minnesota
Start date October 2014
End date May 2015
Trial size 195 participants
Trial identifier NCT02436070, 1409-082


BACKGROUND Asthma is a prevalent and troublesome pediatric condition. In 2013, Emergency Department (ED) providers treated over 3,500 cases of asthma-related complaints at Children's Hospitals and Clinics of Minnesota. Pediatric ED visits for asthma exceeds billions of dollars annually when including direct cost and lost productivity. Many of these visits and resultant costs are avoidable. Patients with well-controlled asthma do not typically exhibit these patterns, while patients with poorly controlled asthma show patterns of increased utilization of healthcare resources and lower quality of life. Evidence suggests that a text message reminder and educational program might positively influence pediatric asthma care practices.

RESEARCH QUESTION Does a targeted ED based text message intervention program improve outpatient follow-up and routine preventive care in pediatric asthma patients?

METHODS Study subjects will be block randomized based on age and insurance group. The experimental group will receive text messages with guidance towards follow-up care with their PCP and the importance of the flu vaccine for children with asthma. The control group will receive a series of educational self-care and health based text messages unrelated to asthma or the flu vaccine. Some self-report of behaviors will be captured via text message response.

ANALYSIS Primary outcomes for the educational versus targeted text message groups will be compared use Chi-square tests. Additional adjustments may be applied for missing data or if, despite randomization, there is substantial imbalance between group in key covariates (eg race/ethnicity, insurance type or asthma severity.)

United States No locations recruiting
Other countries No locations recruiting

Study Design

Allocation randomized
Intervention model parallel assignment
Masking single blind (subject)
Primary purpose supportive care
(Active Comparator)
Subjects receive general, health-related text messages applicable for children with asthma.
text messages
Subjects received text messages
Subjects receive specific, targeted text messages for post-emergency department discharge asthma care.
text messages
Subjects received text messages

Primary Outcomes

Follow-up care with primary care provider
time frame: 1 week after emergency department discharge

Secondary Outcomes

Influenza vaccine
time frame: 30 days after emergency department discharge
Return visit to the emergency department
time frame: 30 days after the inaugural emergency department visit

Eligibility Criteria

Male or female participants from 4 years up to 17 years old.

Inclusion Criteria: - Caregivers of patients aged 4 - 17 years (inclusive) will be eligible for study participation if they meet the following criteria: 1. Presentation to the ED with a chief complaint related to an asthma exacerbation such as shortness of breath, respiratory distress, wheezing, etc… 2. Receive an albuterol treatment in the ED 3. Previous history of asthma as represented in the medical record or by parental report 4. Have a cell phone that is able to receive text messages 5. Able to communicate and provide consent in English or Spanish Exclusion Criteria: - Caregivers of patients will be excluded from this study for the following reasons: 1. First episode of wheezing 2. Admitted to the hospital 3. Co-morbid respiratory disease: 1. Cystic fibrosis 2. Bronchiectasis 3. Pulmonary hypertension 4. Other chronic lung disease 4. Current cancer diagnosis 5. Previous cardiovascular surgery 6. Inflammatory bowel disease 7. Sickle Cell disease

Additional Information

Official title Use of Text Messages to Improve Care For Children Following an ED Visit for Asthma
Trial information was received from ClinicalTrials.gov and was last updated in May 2015.
Information provided to ClinicalTrials.gov by Children's Hospitals and Clinics of Minnesota.